Olari, Lia-Raluca
Bauer, Richard
Gil Miró, Marta
Vogel, Verena
Cortez Rayas, Laura
Groß, Rüdiger
Gilg, Andrea
Klevesath, Raphael
Rodríguez Alfonso, Armando A.
Kaygisiz, Kübra
Rupp, Ulrich
Pant, Pradeep
Mieres-Pérez, Joel
Steppe, Lena
Schäffer, Ramona
Rauch-Wirth, Lena
Conzelmann, Carina
Müller, Janis A.
Zech, Fabian
Gerbl, Fabian
Bleher, Jana
Preising, Nico
Ständker, Ludger
Wiese, Sebastian
Thal, Dietmar R.
Haupt, Christian
Jonker, Hendrik R. A.
Wagner, Manfred
Sanchez-Garcia, Elsa
Weil, Tanja
Stenger, Steffen
Fändrich, Marcus
von Einem, Jens
Read, Clarissa
Walther, Paul
Kirchhoff, Frank
Spellerberg, Barbara
Münch, Jan http://orcid.org/0000-0001-7316-7141
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (MU 4485/1-1, 436586093, EXC 2033 - 390677874 - RESOLV, EXC 2033 - 390677874 - RESOLV, CRC1279)
HORIZON EUROPE Framework Programme (801459 - FP-RESOMUS, 801459 - FP-RESOMUS)
Universitätsklinikum Ulm
Article History
Received: 23 November 2022
Accepted: 25 April 2023
First Online: 17 May 2023
Declarations
:
: D.R.T. received speaker honorary or travel reimbursement from Biogen (USA) and UCB (Brussels, Belgium), and collaborated with Novartis Pharma AG (Basel, Switzerland), Probiodrug (Halle (Saale), Germany), GE Healthcare (Amersham, UK), and Janssen Pharmaceutical Companies (Beerse, Belgium). The other authors declare no conflict of interest.